We aimed to understand how zinc interacts with diabetes treatment through the lens of bee venom and zinc oxide nanoparticles. By creating a nanofilm using these components, we observed targeted therapeutic effects that may help manage diabetes effectively.
The combination of zinc oxide nanoparticles with bee venom significantly enhanced its ability to inhibit enzymes related to carbohydrate digestion, specifically α-amylase and α-glucosidase. Our findings indicated that the nanofilm achieved better results than bee venom alone, with lower inhibitory concentration values, showcasing its potential as an effective antidiabetic agent.
Furthermore, the nanofilm also demonstrated higher anti-inflammatory activity, offering an expansive view of the therapeutic benefits associated with this combination. While it’s important to note that zinc was just one element of the treatment, our research underscores its significance within this enhanced formulation aimed at combatting diabetes.